• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Underrepresentation of Women in Recent Landmark Kidney Trials: The Gender Gap Prevails.

作者信息

Vinson Amanda J, Collister David, Ahmed Sofia, Tennankore Karthik

机构信息

Division of Nephrology, Department of Medicine, Dalhousie University, Nova Scotia, Canada.

Nova Scotia Health, Halifax, Canada.

出版信息

Kidney Int Rep. 2022 Sep 2;7(11):2526-2529. doi: 10.1016/j.ekir.2022.08.022. eCollection 2022 Nov.

DOI:10.1016/j.ekir.2022.08.022
PMID:36531883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9751686/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20b/9751686/8fd8a82a976e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20b/9751686/699c97d3b839/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20b/9751686/8fd8a82a976e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20b/9751686/699c97d3b839/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20b/9751686/8fd8a82a976e/gr2.jpg

相似文献

1
Underrepresentation of Women in Recent Landmark Kidney Trials: The Gender Gap Prevails.近期具有里程碑意义的肾脏试验中女性代表性不足：性别差距依然存在。
Kidney Int Rep. 2022 Sep 2;7(11):2526-2529. doi: 10.1016/j.ekir.2022.08.022. eCollection 2022 Nov.
2
Underrepresentation and undertreatment of women in hematology: An unsolved issue.血液学领域中女性患者的代表性不足和治疗不足：一个尚未解决的问题。
Res Pract Thromb Haemost. 2022 Jul 21;6(5):e12767. doi: 10.1002/rth2.12767. eCollection 2022 Jul.
3
The impact of cardiovascular disease prevalence on women's enrollment in landmark randomized cardiovascular trials: a systematic review.心血管疾病患病率对女性参与 landmark 随机心血管临床试验的影响：一项系统评价。
J Gen Intern Med. 2012 Jan;27(1):93-8. doi: 10.1007/s11606-011-1768-8. Epub 2011 Jun 29.
4
Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic Malignancies.与 FDA 批准的癌症药物相关的临床试验中的性别代表性在实体瘤和血液系统恶性肿瘤之间存在差异。
Oncologist. 2021 Feb;26(2):107-114. doi: 10.1002/onco.13534. Epub 2020 Oct 7.
5
Gender disparity in living renal transplant donation.活体肾移植捐赠中的性别差异。
Am J Kidney Dis. 2000 Sep;36(3):534-40. doi: 10.1053/ajkd.2000.9794.
6
Inclusion of Under-Represented Racial and Ethnic Groups in Cardiovascular Clinical Trials.纳入代表性不足的种族和族裔群体进行心血管临床试验。
Heart Lung Circ. 2022 Sep;31(9):1263-1268. doi: 10.1016/j.hlc.2022.06.668. Epub 2022 Jul 16.
7
Gender Representation at Neurological Surgery Conferences.神经外科学术会议中的性别代表性。
World Neurosurg. 2019 Sep;129:453-459. doi: 10.1016/j.wneu.2019.06.062. Epub 2019 Jun 15.
8
Women in Academic Science: A Changing Landscape.女性在学术科学界：变化中的风景。
Psychol Sci Public Interest. 2014 Dec;15(3):75-141. doi: 10.1177/1529100614541236.
9
Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap.心力衰竭临床试验中的女性代表性：入组障碍及缩小差距的策略。
Am Heart J Plus. 2022 Jan;13. doi: 10.1016/j.ahjo.2022.100093. Epub 2022 Jan 30.
10
Gender Disparity in Academic Gastroenterology: Beginning of the End of the Underrepresentation of Women?学术消化内科中的性别差异：女性代表性不足现象的终结之始？
Dig Dis Sci. 2022 Feb;67(2):380-387. doi: 10.1007/s10620-020-06692-7. Epub 2020 Nov 3.

引用本文的文献

1
Sex and gender considerations in randomized controlled trials in critical care nephrology: a meta-epidemiologic study.危重症肾脏病学随机对照试验中的性别与性别的考量：一项元流行病学研究
BMC Med. 2025 Jul 1;23(1):386. doi: 10.1186/s12916-025-04202-y.
2
Factors and Disparities Influencing Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists Initiation in the United States: A Scoping Review of Evidence.影响美国钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽1受体激动剂起始使用的因素及差异：证据的范围综述
Pharmacy (Basel). 2025 Mar 19;13(2):46. doi: 10.3390/pharmacy13020046.
3
The 60:40 conundrum: are women with CKD discriminated after referral to a nephrology clinic?

本文引用的文献

1
Gender differences in adverse event reports associated with antidiabetic drugs.与抗糖尿病药物相关的不良事件报告中的性别差异。
Sci Rep. 2020 Oct 16;10(1):17545. doi: 10.1038/s41598-020-74000-4.
2
Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials.在 2 型糖尿病中 SGLT-2 抑制剂和 GLP-1 受体激动剂对心血管结局的性别差异：心血管结局试验的系统评价和荟萃分析。
Diabetes Metab Syndr. 2020 May-Jun;14(3):181-187. doi: 10.1016/j.dsx.2020.02.012. Epub 2020 Feb 26.
3
Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
60:40难题：慢性肾脏病女性转诊至肾病科门诊后是否受到歧视？
Clin Kidney J. 2025 Feb 24;18(3):sfaf046. doi: 10.1093/ckj/sfaf046. eCollection 2025 Mar.
4
Association of Kidney Function With Incident Heart Failure: An Analysis of the Women's Health Initiative.肾功能与新发心力衰竭的关联：妇女健康倡议研究分析
J Am Heart Assoc. 2025 Mar 4;14(5):e037051. doi: 10.1161/JAHA.124.037051. Epub 2025 Feb 25.
5
Unveiling the role of sex in the metabolism of indoxyl sulfate and apixaban.揭示性别在硫酸吲哚酚和阿哌沙班代谢中的作用。
Sci Rep. 2025 Feb 19;15(1):6075. doi: 10.1038/s41598-025-90405-5.
6
Guidelines for sex-specific considerations to improve rigor in renal research and how we got there.提高肾脏研究严谨性的性别特异性考量指南以及我们是如何达成这些指南的。
Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F204-F217. doi: 10.1152/ajprenal.00136.2024. Epub 2024 Dec 20.
7
Revisiting sex as a biological variable in hypertension research.重新审视高血压研究中的性别生物学变量。
J Clin Invest. 2024 Sep 3;134(17):e180078. doi: 10.1172/JCI180078.
8
Systematic Review of Women Leading and Participating in Nephrology Randomized Clinical Trials.女性主导和参与肾脏病学随机临床试验的系统评价。
Kidney Int Rep. 2024 Jan 28;9(4):898-906. doi: 10.1016/j.ekir.2024.01.031. eCollection 2024 Apr.
9
Sex Inequities in Clinical Trials and Trial Leadership.临床试验及试验领导中的性别不平等现象。
Kidney Int Rep. 2024 Feb 11;9(4):740-742. doi: 10.1016/j.ekir.2024.02.015. eCollection 2024 Apr.
10
Sex and gender-based analysis and diversity metric reporting in acute care trials published in high-impact journals: a systematic review.高影响力期刊发表的急性护理试验中的基于性别的分析和多样性指标报告：系统评价。
BMJ Open. 2024 May 7;14(5):e081118. doi: 10.1136/bmjopen-2023-081118.
新型降糖药物与二甲双胍联合治疗 2 型糖尿病的心血管疗效的性别差异。
J Am Heart Assoc. 2020 Jan 7;9(1):e012940. doi: 10.1161/JAHA.119.012940. Epub 2020 Jan 4.
4
Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of TOPCAT Trial.螺内酯在射血分数保留的心力衰竭中的疗效和反应的性别差异：TOPCAT 试验的二次分析。
JACC Heart Fail. 2019 Mar;7(3):228-238. doi: 10.1016/j.jchf.2019.01.003.
5
Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors.钠-葡萄糖协同转运蛋白 2 抑制剂相关生殖器感染的比较风险。
Diabetes Obes Metab. 2019 Feb;21(2):434-438. doi: 10.1111/dom.13531. Epub 2018 Oct 11.
6
Does Gender Influence the Cardiovascular Benefits Observed with Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis.性别是否会影响钠-葡萄糖协同转运蛋白2（SGLT-2）抑制剂所带来的心血管益处？一项Meta回归分析。
Cardiol Ther. 2017 Jun;6(1):129-132. doi: 10.1007/s40119-016-0075-1. Epub 2016 Nov 28.
7
Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials.多元化临床试验的对话：成功吸引女性和少数族裔参与临床试验的策略。
J Womens Health (Larchmt). 2012 Jul;21(7):713-6. doi: 10.1089/jwh.2012.3733.
8
The number, quality, and coverage of randomized controlled trials in nephrology.肾脏病学中随机对照试验的数量、质量和覆盖范围。
J Am Soc Nephrol. 2004 Feb;15(2):411-9. doi: 10.1097/01.asn.0000100125.21491.46.
9
How the new NIH Guidelines on Inclusion of Women and Minorities apply: efficacy trials, effectiveness trials, and validity.美国国立卫生研究院（NIH）关于纳入女性和少数族裔的新指南如何应用：疗效试验、效果试验和效度
J Consult Clin Psychol. 1996 Oct;64(5):851-5. doi: 10.1037//0022-006x.64.5.851.